Invention Grant
- Patent Title: Dopamine D3 receptor antagonist compounds
-
Application No.: US16261206Application Date: 2019-01-29
-
Publication No.: US10654842B2Publication Date: 2020-05-19
- Inventor: Susanna Cremonesi , Fabrizio Micheli , Teresa Semeraro , Luca Tarsi
- Applicant: Indivior UK Limited
- Applicant Address: GB Hull
- Assignee: INDIVIOR UK LIMITED
- Current Assignee: INDIVIOR UK LIMITED
- Current Assignee Address: GB Hull
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Agent Edward D. Grieff
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@65e006e4 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@165f1080
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D403/12 ; C07D401/14 ; C07D405/14 ; C07D403/14 ; C07D409/14 ; C07D417/14 ; C07D471/04 ; C07D493/08
Abstract:
The disclosure is directed to novel dopamine D3 receptor antagonists, processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, including treating drug dependency and psychosis.
Public/Granted literature
- US20190300514A1 DOPAMINE D3 RECEPTOR ANTAGONIST COMPOUNDS Public/Granted day:2019-10-03
Information query
